Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
    Chen, Xufeng
    Glytsou, Christina
    Zhou, Hua
    Narang, Sonali
    Reyna, Denis E.
    Lopez, Andrea
    Sakellaropoulos, Theodore
    Gong, Yixiao
    Kloetgen, Andreas
    Yap, Yoon Sing
    Wang, Eric
    Gavathiotis, Evripidis
    Tsirigos, Aristotelis
    Tibes, Raoul
    Aifantis, Iannis
    CANCER DISCOVERY, 2019, 9 (07) : 890 - 909
  • [32] Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Kuwahara, Yasumichi
    Yoshida, Tatsushi
    DISEASES, 2025, 13 (01)
  • [33] Inhibition of ERK1/2 Reverses Venetoclax-Induced Autophagy to Overcome Resistance in Acute Myeloid Leukemia
    Sharma, Priyanka
    Piya, Sujan
    Baran, Natalia
    Muftuoglu, Muharrem
    Basyal, Mahesh
    Ruvolo, Vivian
    Hindley, Christopher J.
    Dao, Kim-Hien
    Sims, Martin
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2022, 140 : 3093 - 3094
  • [34] Combined Effect of the Cfr Methyltransferase and Ribosomal Protein L3 Mutations on Resistance to Ribosome-Targeting Antibiotics
    Pakula, Kevin K.
    Hansen, Lykke H.
    Vester, Birte
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [35] Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia
    Sakamoto, Kathleen M.
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1449 - 1450
  • [36] A novel approach to overcome drug resistance in acute myeloid leukemia
    Mazewski, Candice
    Platanias, Leonidas C.
    HAEMATOLOGICA, 2023, 108 (11) : 2889 - 2890
  • [37] Venetoclax in adult acute myeloid leukemia
    Hu, Mengci
    Li, Wenzhe
    Zhang, Youshan
    Liang, Caixia
    Tan, Jie
    Wang, Ya
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [38] Boanmycin induces apoptosis and overcomes venetoclax resistance in acute myeloid leukemia
    Wang, Jin-Xing
    Zhang, Peng-Wei
    Yuan, Luo-Wei
    Jiang, Jian
    Cheng, Xiao-Hui
    Li, Ju-Heng
    Tang, Mei-Qin
    Fan, Jiao-Yang
    Zhu, Wei
    Lei, Yong
    Tian, Fa-Qing
    ONCOLOGIE, 2024, 26 (05) : 743 - 752
  • [39] Targeting Extracellular Vesicle Secretion As a Strategy to Overcome Microenvironment Mediated Drug Resistance in Acute Myeloid Leukemia
    Kumar, Palani Kumar
    Ganesan, Saravanan
    Balasundaram, Nithya
    David, Sachin
    Venkatraman, Arvind
    Kulkarni, Uday Prakash
    Korula, Anu
    George, Biju
    Balasubramanian, Poonkuzhali
    Mathews, Vikram
    BLOOD, 2019, 134
  • [40] Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
    Griffioen, Mila S.
    de Leeuw, David C.
    Janssen, Jeroen J. W. M.
    Smit, Linda
    CANCERS, 2022, 14 (14)
12345